• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆中糖萼素的新型酶联免疫吸附测定法。

New enzyme-linked immunosorbent assay for glycocalicin in plasma.

作者信息

Kunishima S, Hayashi K, Kobayashi S, Naoe T, Ohno R

机构信息

Department of Central Clinical Laboratory, Meijo Hospital, Nagoya, Japan.

出版信息

Clin Chem. 1991 Feb;37(2):169-72.

PMID:1993320
Abstract

A new sandwich-type enzyme-linked immunosorbent assay for quantifying glycocalicin, a proteolytic fragment of platelet membrane glycoprotein Ib, is described. The assay is based on the use of two monoclonal antibodies raised against glycoprotein Ib and involves the avidin-biotin technique. The detection limit is 7 micrograms/L and the range of glycocalicin determined in plasma is 0.01 to 1 mg/L. Assay time is 2 h. The intra-assay CV ranged from 3.6% to 5.2%, the interassay CV from 5.4% to 8.0%. Analytical recovery of purified glycocalicin added to a plasma pool averaged 96%. In 36 healthy subjects, the mean glycocalicin concentration in plasma was 0.36 (SD 0.07) mg/L (2.7 nmol/L). We conclude that this assay is suitable for measuring glycocalicin in plasma and is also more sensitive and precise than the previously published immunoassays based on competitive binding assay.

摘要

本文描述了一种用于定量血小板膜糖蛋白 Ib 的蛋白水解片段糖萼素的新型夹心型酶联免疫吸附测定法。该测定法基于使用两种针对糖蛋白 Ib 产生的单克隆抗体,并涉及抗生物素蛋白-生物素技术。检测限为 7 微克/升,血浆中糖萼素的测定范围为 0.01 至 1 毫克/升。测定时间为 2 小时。批内变异系数范围为 3.6%至 5.2%,批间变异系数为 5.4%至 8.0%。添加到血浆库中的纯化糖萼素的分析回收率平均为 96%。在 36 名健康受试者中,血浆中糖萼素的平均浓度为 0.36(标准差 0.07)毫克/升(2.7 纳摩尔/升)。我们得出结论,该测定法适用于测量血浆中的糖萼素,并且比先前基于竞争性结合测定法发表的免疫测定法更灵敏、更精确。

相似文献

1
New enzyme-linked immunosorbent assay for glycocalicin in plasma.血浆中糖萼素的新型酶联免疫吸附测定法。
Clin Chem. 1991 Feb;37(2):169-72.
2
Rapid detection of plasma glycocalicin by a latex agglutination test. A useful adjunct in the differential diagnosis of thrombocytopenia.通过乳胶凝集试验快速检测血浆糖钙素。血小板减少症鉴别诊断中的一项有用辅助检查。
Am J Clin Pathol. 1993 Nov;100(5):579-84. doi: 10.1093/ajcp/100.5.579.
3
Platelet storage results in a redistribution of glycoprotein Ib molecules. Evidence for a large intraplatelet pool of glycoprotein Ib.血小板储存导致糖蛋白Ib分子重新分布。存在大量血小板内糖蛋白Ib池的证据。
J Clin Invest. 1988 Jun;81(6):1734-40. doi: 10.1172/JCI113513.
4
A new competitive binding enzyme-linked immunosorbent assay for glycocalicin in plasma and platelet concentrate supernatants.一种用于检测血浆和血小板浓缩物上清液中糖钙蛋白的新型竞争性结合酶联免疫吸附测定法。
Thromb Res. 1990 Aug 1;59(3):497-507. doi: 10.1016/0049-3848(90)90410-e.
5
Plasma glycocalicin. An aid in the classification of thrombocytopenic disorders.血浆糖钙蛋白。血小板减少症分类的辅助手段。
N Engl J Med. 1987 Oct 22;317(17):1037-42. doi: 10.1056/NEJM198710223171701.
6
Glycocalicin: a new assay--the normal plasma levels and its potential usefulness in selected diseases.糖钙蛋白:一种新的检测方法——正常血浆水平及其在特定疾病中的潜在用途。
Blood. 1994 Feb 1;83(3):691-702.
7
Evidence that glycocalicin circulates in normal plasma.糖钙蛋白在正常血浆中循环的证据。
J Clin Invest. 1984 Mar;73(3):794-9. doi: 10.1172/JCI111273.
8
Serum thrombopoietin and plasma glycocalicin concentrations as useful diagnostic markers in thrombocytopenic disorders.血清血小板生成素和血浆糖萼蛋白浓度作为血小板减少性疾病的有用诊断标志物。
Eur J Haematol. 1996 Jul;57(1):68-71. doi: 10.1111/j.1600-0609.1996.tb00492.x.
9
Plasma glycocalicin as a source of GPIbalpha in the von Willebrand factor ristocetin cofactor ELISA.在血管性血友病因子瑞斯托霉素辅因子酶联免疫吸附测定中,血浆糖钙素作为糖基磷脂酰肌醇锚定蛋白α的来源。
Thromb Haemost. 2005 Jan;93(1):165-71. doi: 10.1160/TH04-04-0402.
10
Platelet glycocalicin.血小板糖蛋白
Methods Enzymol. 1992;215:289-94. doi: 10.1016/0076-6879(92)15071-j.

引用本文的文献

1
Systemic lupus erythematosus and C1q: A quantitative ELISA for determining C1q levels in serum.系统性红斑狼疮与C1q:一种用于测定血清中C1q水平的定量酶联免疫吸附测定法。
Biotechnol J. 2009 Aug;4(8):1210-4. doi: 10.1002/biot.200800273.
2
Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction.心肌细胞中纤溶酶原激活物抑制剂-1表达增加会导致心肌梗死后心脏纤维化。
Am J Pathol. 2004 Feb;164(2):449-56. doi: 10.1016/S0002-9440(10)63135-5.